[Oxford session] She Started It: A Film Screening
Saïd Business School , University of Oxford , Oxford , OX1 1HP
June 13, 2017 from 19:30 PM to 22:30 PM (BST)
$10 - $35
96% of venture capitalists are men1. Women still account for less than 10% of founders for high growth firms2 and earn only 12.9% of computer science degrees3. "She Started It" gives a new face to the image of the tech entrepreneur: a female face.
Join Johnson & Johnson Innovation, JLABS and the Innovation Forum for a film screening of "She Started It", a new documentary film that follows five trailblazing young female entrepreneurs through their journeys of entrepreneurship.
The movie screening will be followed by a panel discussion featuring local influential women in business. All ages are welcome!
View the trailer for the film here: https://www.youtube.com/watch?v=hcGGrUx666s
2"Sources of Economic Hope" by Kauffman Foundation
3Computing Research Association study
Cambridge 15 June
17:30 | Registration Opens & Networking Reception
18:30 | Film Screening of "She Started It"
19:30 | Panel Discussion
20:30 | Programme Close
Letizia Goretti | Director, Portfolio Management and Business Operations, Johnson & Johnson Innovation read bio»
Joanna Gould | Founder, Visus-Nano read bio»
Danuta Jeziorska | Oxford President, Innovation Forum read bio»
Eva-Lotta Allan | Chief Business Officer, Immunocore read bio»
FREE | General Public
Saïd Business School
University of Oxford
Park End St, Oxford OX1 1HP, UK
Letizia Goretti | Director, Portfolio Management and Business Operations, Johnson & Johnson Innovation
Letizia is the Director for Portfolio Management and Business Operations, at Johnson & Johnson Innovation, London. In this role, she has responsibility for coordinating the operational and portfolio management of the Innovation Center, including governance and metrics for the portfolio, internal and external stakeholders engagement, as well as designing and sustaining modus operandi to enable the J&J innovation and collaboration strategy in close partnership with all the IC leadership functions. Prior joining the London IC team, Letizia was Established Brands and Life Cycle Management Director for the Janssen EMEA commercial strategy organization. In this position she was responsible for leading the strategy and performance of a portfolio of 60 plus mature products, delivering rationalization targets, divestiture projects and opportunities for collaboration across regions and global functions. Letizia brings a broad and extensive background across quality, CMC disciplines, supply chain launch management, alliance management and business development. Letizia has track record of creating effective governances and collaborative environments, integrating silos and enabling teams and individuals to excel. Letizia received her MSc in Theoretical Chemistry from University of Perugia, Italy.
Joanna Gould | Founder,Visus-Nano
Joanna Gould (Jo), is a final year PhD student from the University of Southampton and co-founder of the Stevange based start-up, VisusNano. After completing an MRes and Bsc in Foetal health and Neuroscience from the University of Manchester, Jo left academia to work in the financial sector at the Bank of America. She was subsequently driven to return to academia to undertake a PhD at the University of Southampton in the field of foetal neural development. This work has resulted in numerous awards. Jo also is the co-founder of several start-ups, not affiliated with her PhD work in Southampton. She is Chief Business Development officer and co-founder of VisusNano, an award-winning ophthalmology start-up focussed on the development of novel cataract technologies. Jo has already benefited from the experience of many mentors in her short career in start-ups and is thus passionate about helping and supporting other young women in science and technology realise their ambitions.
Danuta Jeziorska | Oxford President, Innovation Forum
Dr Danuta Mariola Jeziorska is a Postdoctoral Research Scientist at the MRC Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford. Her research focuses on understanding how genes are turned on and off during red blood cell formation. Before moving to Oxford, Danuta completed her PhD in Systems Biology from the University of Warwick and obtained a BSc degree in Biotechnology from the University of Silesia in Poland. Danuta is passionate about combining her academic background with her strong interest in innovation and entrepreneurship. She is current leading the Oxford branch of the Innovation Forum, a non-profit global network that aims to accelerate innovation by inspiring and educating the next generation of entrepreneurs and strengthening connections between academics, industry and healthcare professionals. Danuta is also very passionate about supporting women in the academic and entrepreneurial ecosystems. She is a member of the directors board of TechTonic that aims to address the lack of support for women in the technology sector in Oxfordshire.
Eva-Lotta Allan | Chief Business Officer, Immunocore
Eva-Lotta Allan has ~30 years of corporate and business development experience from the biotechnology and life science industry of private and public companies In the UK and EU. She joined Immunocore as Chief Business Officer in May 2013. Since joining, Immunocore has raised £205 ($320) million in a Series A financing round (the largest private round in Europe and second largest globally in the life science sector), established four major discovery partnerships with GSK, Genentech, MedImmune and Lilly and entered into two clinical trial collaborations. Eva-Lotta is an elected member of the BioIndustry Association (BIA) Board of Directors and a Non-executive Director of Targovax (Oslo) and was previously on the Board of Isconova (Sweden). Prior to joining Immunocore, Eva-Lotta was Chief Business Officer at Ablynx for ~7 years where she concluded a significant number of pharmaceutical partnerships and contributed to its IPO and follow-on fundraising events. Prior to Ablynx, Eva-Lotta spent over 6 years with Vertex Pharmaceuticals as Senior Director of Global Business Development and European Site Operations. She started her career as a bench scientist at the Tumour Biology department at the Karolinska Institute in Stockholm and spent a year at University of Nebraska Medical Centre.